The Plaintiffs in the Depo-Provera litigation allege that they developed an intracranial meningioma (brain tumor) caused by use of Depo-Provera—a widely used contraceptive that is injected intramuscularly every three months. The lawsuits allege that the Defendants, pharmaceutical manufacturers including Pfizer, knew of the risks and incidence rates of women developing meningiomas following use of Depo-Provera, and that they failed to adequately warn of this risk and promote safer drugs, including a lower dose of medroxyprogesterone acetate and its administration through subcutaneous injection.
Depo-Provera lawsuits were filed nationwide following epidemiological studies finding that the injection of Depo-Provera increased the risk of cerebral meningioma, increasing with longer duration of use.
“I am deeply honored to serve on the Plaintiffs’ Leadership team on this important litigation,” said Courtney Mohammadi. “Millions of women received Depo-Provera injections without being informed of the risk of developing meningiomas—and many women later developed meningiomas that caused debilitating migraines, seizures, loss of vision, and other adverse effects. I look forward to litigating this case with my colleagues and seeking accountability for the harm our clients have suffered.”
Pope McGlamry has successfully represented thousands of people injured by pharmaceutical drugs and medical devices in lawsuits nationwide. If you used Depo-Provera for at least one year and were later diagnosed with a meningioma, Pope McGlamry is available to help you seek compensation from the manufacturers of Depo-Provera.
Please call the attorneys at Pope McGlamry for a free case evaluation or submit your evaluation form.
